List of Zynerba Pharmaceuticals patents

List of Zynerba Pharmaceuticals patents

List of Eli Lilly patents

List of Texas Heart Institute patents

List of Alfa Laval patents

List of patents in the Cloud management industry

List of funding rounds for AvantStay

Patents where

Current Assignee

Name

is

Zynerba Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent RE47885 Use of cannabidiol prodrugs in pharmaceutical compositions	Patent RE47885 was granted and assigned to Zynerba Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	RE47885	March 3, 2020
	‌ US Patent 9533942 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles	Patent 9533942 was granted and assigned to Zynerba Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.		Zynerba Pharmaceuticals		United States Patent and Trademark Office	9533942	January 3, 2017
	‌ US Patent 10471022 Treatment of fragile X syndrome with cannabidiol	Patent 10471022 was granted and assigned to Zynerba Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	10471022	November 12, 2019
	‌ US Patent 10213390 Treatment of fragile X syndrome with cannabidiol	Patent 10213390 was granted and assigned to Zynerba Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	10213390	February 26, 2019
	‌ US Patent 10314792 Treatment of autism with cannabidiol	Patent 10314792 was granted and assigned to Zynerba Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	10314792	June 11, 2019
	‌ US Patent 9957246 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same	Patent 9957246 was granted and assigned to Zynerba Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	9957246	May 1, 2018
	‌ US Patent 10568848 Treatment of autism with cannabidiol	Patent 10568848 was granted and assigned to Zynerba Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	10568848	February 25, 2020
	‌ US Patent 11458110 Treatment of Fragile X Syndrome with cannabidiol		Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	11458110	October 4, 2022
	‌ US Patent 11458109 Treatment of 22Q11.2 deletion syndrome with cannabidiol		Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	11458109	October 4, 2022
	‌ US Patent 9695143 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same	Patent 9695143 was granted and assigned to Zynerba Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.		Zynerba Pharmaceuticals		United States Patent and Trademark Office	9695143	July 4, 2017
	‌ US Patent 10758497 Treatment of fragile x syndrome with cannabidiol	Patent 10758497 was granted and assigned to Zynerba Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	10758497	September 1, 2020
	‌ US Patent 11779549 Treatment of Fragile X Syndrome with cannabidiol	Patent 11779549 was granted and assigned to Zynerba Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.	Zynerba Pharmaceuticals	Zynerba Pharmaceuticals		United States Patent and Trademark Office	11779549	October 10, 2023

12 results

0 selected

12 results

0 selected